The poor outcome of second primary oral squamous cell carcinoma is attributed to Bmi1 upregulation
Qinchao Hu(Sun Yat-sen University), Bin Cheng(Columbia University Irving Medical Center)
Cited by 22
Related Papers
Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening
|Biomedicine & Pharmacotherapy|2019|200
Metformin as a senostatic drug enhances the anticancer efficacy of CDK4/6 inhibitor in head and neck squamous cell carcinoma
|Cell Death and Disease|2020|71
Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis
|Scientific Reports|2016|69
Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2
|International Journal of Molecular Medicine|2016|62
Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity
|Clinical Cancer Research|2019|51